Press Release

Updates and news NEWS Driving Innovation Forward: SHIFTBIO Presents at the 2026 KDDF Global Biotech Showcase

Updates and news NEWS SHIFTBIO Recognized as an Excellent Corporate R&D Center and Designated as a Military Service-Designated Organization

Updates and news NEWS SHIFTBIO Unveils 'NNP Design AI' and Delivery Platforms at ASGCT 2026

Updates and news NEWS Beyond Anti-CD47 Antibodies: SIRPα-Engineered Vesicles Open New Horizons in Immunology

Updates and news NEWS Happy New Year 2026 from SHIFTBIO

Updates and news NEWS SHIFTBIO’s Latest SIRP-NNP Research Published in Kidney International

Updates and news NEWS SHIFTBIO Participates in the 7th CNS Drug Delivery Summit in Boston

Updates and news NEWS SHIFTBIO Showcases AI-Driven Drug Delivery at 2025 DIPS Global Tech Con

Updates and news NEWS SHIFTBIO Achieves Key Global Milestones in NNP Pipeline Development

Updates and news NEWS SHIFTBIO Shares Its Journey of Innovation at Try Everything 2025

Updates and news NEWS SHIFTBIO × Dassault Systèmes: Driving Innovation in Drug Development

Updates and news NEWS SHIFTBIO at the Forefront of EV Innovation

Updates and news NEWS MAKING INNOVATION ACCESSIBLE: Breakthrough Published in Biomaterials

Updates and news NEWS One of SHIFTBIO's leading program has been accepted for publication in Nature Communications

Updates and news NEWS SHIFTBIO is sending warm wishes to everyone for a Merry Christmas and a Happy New Year

Updates and news NEWS SHIFTBIO INC Awarded as an Outstanding "Global Collaboration Company"

Updates and news NEWS SHIFTBIO INC. was honored to participate in the Exosome-Based Therapeutic Development Summit held in Boston

Updates and news NEWS SHIFTBIO INC. has invited to the 'Korea Conference 2024' for the third consecutive year

Updates and news NEWS SHIFTBIO INC. is delighted to share the preprint of our second program, HIF1α-NNP

Updates and news NEWS SHIFTBIO INC. was honored as the Top Poster at the 'EASL Congress 2024'

Updates and news NEWS Gi-Hoon Nam, CEO of SHIFTBIO INC., Featured Speaker at ISCT 2024 in Vancouver

Updates and news NEWS Dr. Dolores Di Vizio, a world-class scientist in circulating extracellular vesicles, has joined SHIFTBIO INC’s Scientific Advisory Board (SAB)

Updates and news NEWS SHIFTBIO INC. is delighted to share the preprint of our lead program, SIRP-NNP

Updates and news NEWS SHIFTBIO INC. Participates in the '2024 EV Characterization & Analytic Development Summit' in Boston, MA

Updates and news NEWS SHIFTBIO INC. has participated in the ‘Biocom Global Partnering' event

Updates and news NEWS SHIFTBIO INC. were invited to the “Korea-Germany Innovation Partnership Forum" in Berlin, Germany

Updates and news NEWS SHIFTBIO's SIRP-EV achieved an Orphan Drug Designation(ODD) for Acute Liver Failure from FDA